Furoscix is a pH-neutral formulation of furosemide, a loop diuretic, designed for subcutaneous (SC) administration via a wearable, single-use, pre-programmed on-body infusor for outpatient ...
The following is a summary of “Diuretic Tolerance to Repeated-Dose Furosemide in Infants Born Very Preterm with ...
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
India has donated urgently-needed medicines to Sri Lanka responding to an urgent request from Colombo, the Indian High ...
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
Furoscix is expected to be available for CKD patients in April 2025. The Food and Drug Administration (FDA) has expanded the approval of Furoscix ® (furosemide injection) to include the treatment ...
The Government of India yesterday donated 50,000 ampoules of Furosemide injection (20mg/2ml) to help address the immediate ...
In response to an urgent request from the Sri Lankan Government, India has gifted 50,000 ampoules of Furosemide injection ...
He also has untreated sleep apnea. He would like to try one of the GLP-1 drugs to lose some weight, but I am concerned about ...
India has donated essential medicines to Sri Lanka following an urgent request. The aid, including Furosemide injections and ...
Furosemide injection was previously approved to treat congestion from fluid buildup in adults with chronic heart failure. Last year, the drug developer noted that FDA feedback from a 2023 Type D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback